Lawmakers Probing Firm's Decision to Charge $89,000 for Muscular Dystrophy Drug

Two congressional lawmakers are investigating how Marathon Pharmaceuticals set a price of $89,000 for an old steroidal drug that has been available for decades in Europe at a fraction of that price.

from WSJ.com: US Business http://ift.tt/2lHz6ML
via IFTTT